|
|
Mr. Lefkoff's representative life science investments include Hauser Chemical Research (NASDAQ: HAUS), NeXstar Pharmaceuticals (sold to Gilead Sciences), Array BioPharma (NASDAQ: ARRY), Dharmacon (sold to Fisher Scientific), Genomica (sold to Exelixis), ARCA biopharma (NASDAQ: ABIO), and Miragen Therapeutics. Representative information technology investments include McData (sold to EMC), Atlantes (sold to Metromail), Compatible Systems (sold to Cisco Systems), Wall Street on Demand (sold to Goldman Sachs), Lefthand Networks (sold to Hewlett Packard), and Market Force Information. Representative natural foods retailing investments include Horizon Organic Dairy (sold to Dean Foods), Alfalfa's Markets (sold to Wild Oats), and Fresh & Wild PLC (sold to Whole Foods). Mr. Lefkoff also serves on the board of Trust Company of America and University License Equity Holding, Inc (ULEHI) at the University of Colorado. He is the past Chairman of the Venture Capital Association of Colorado and is an Adjunct Professor of Finance at the University of Colorado Leeds School of Business. Mr. Lefkoff holds a MBA from University of Chicago (1985) and a BA (summa cum laude) in Economics from Vassar College (1981). Mr. Lefkoff completed a Fellowship in Economic History at the London School of Economics. Mr. Lefkoff is an experienced alpinist and mountain guide with difficult ascents to his credit in the French Alps, Peruvian Andes, and the major ranges of North America. He was a member of the 1986 American Expedition to the North Face of K2 and is a Lifetime Member and past Director of the American Mountain Guides Association. Mr. Lefkoff serves as a Director and Treasurer of The Access Fund, a national climbing advocacy organization. |
